Calmare therapy improved pain in patients with cancer-related neuropathic pain.
Calmare therapy improved quality of life in patients with neuropathic cancer pain.
Consumption of rescue opioid decreased at two-week follow-up after Calmare therapy.
Calmare therapy can be considered for patients with cancer-related neuropathic pain.